Overall rank by patents
#15,078
of 50,000 tracked assignees
USPTO PatentsView assignee record - 19 granted patents across 8 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA).
The verdict
According to USPTO PatentsView, Abclonal ranks #15,078 of 50,000 tracked US assignees by granted-patent volume, with 19 patents across 8 technology areas.
USPTO PatentsView assignee plate
Corpus R15078 · US Corporation #15,078 · 19 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-PAR · TYPE-USCORP · SPAN-YRS · BOOK-RICH
Nearest grant-volume peer: Abu Dhabi National Oil Company (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Abclonal Science · this assignee
42 score
3D Lighting Innovati… · lowest
7 score
What this shows Abclonal Science, Inc. stamps GRANTS-MICRO, MID-PACK, PHOTO-FINISH, CPC-NARROW, INNOV-PAR, CLAIMS-PAR, TYPE-USCORP, SPAN-YRS, BOOK-RICH. Volume places it #15,078 of 50,000; Innovation Score 42.0/100 sits in the top 31% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is Abu Dhabi National Oil Company (±0 grants).
Abclonal Science, Inc. has been granted 19 US utility patents between 2020 and 2025, placing Abclonal Science, Inc. at #15,078 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 8 distinct Cooperative Patent Classification (CPC) subclasses, averaging 8.4 claims per patent with primary concentration in C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA). As a US Corporation, Abclonal Science, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Abclonal sits between Asymchem Laboratories (tianjin) Co., Ltd. (19 patents, rank #15,102) and Ackley Machine Corporation (19 patents, rank #15,110) - the closest US assignees by grant volume. The composite Innovation Score of 42.0/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Grant cadence records the difference between two grant-year windows. Historical data spans 2020 through 2025, with 19 total grants over that period. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The US Corporation classification provides context for the assignee record, not a conclusion about its business strategy.
Claim depth and technology breadth describe this aggregate record. Abclonal Science, Inc.'s 8.4 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 8 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
ASYMCHEM LABORATORIES (TIANJIN) CO., LTD.
19 patents
ATC Logistics & Electronics, Inc.
19 patents
AVIACOMM INC.
19 patents
AVL Test Systems, Inc.
19 patents
Abu Dhabi National Oil Company
19 patents
Accelerated Systems Inc.
19 patents
Achaemenid, LLC
19 patents
Ackley Machine Corporation
19 patents
AbClonal Science, Inc.
19 patents
What this shows Abclonal holds 19 patents at rank #15,106, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #15,106 in granted patent volume.
Other assignees with the most granted patents in Abclonal's primary technology class.
Abclonal's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
42 Top 31% higher than 69% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 1 | 5.3% |
| 2021 | 3 | 15.8% |
| 2022 | 1 | 5.3% |
| 2023 | 8 | 42.1% |
| 2024 | 1 | 5.3% |
| 2025partial year | 5 | 26.3% |
Top 8 of 8 technology areas
Overall rank by patents
#15,078
of 50,000 tracked assignees
42.0 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.